Glassman Wealth Services’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-168
Closed -$3.62K 1625
2023
Q4
$3.62K Buy
168
+161
+2,300% +$2.97K ﹤0.01% 1166
2023
Q3
$130 Sell
7
-183
-96% -$4.27K ﹤0.01% 1952
2023
Q2
$4.81K Sell
190
-200
-51% -$5.03K ﹤0.01% 1007
2023
Q1
$10.1K Buy
390
+278
+248% +$7.44K ﹤0.01% 818
2022
Q4
$2.65K Sell
112
-66
-37% -$1.78K ﹤0.01% 1191
2022
Q3
$5K Buy
178
+31
+21% +$1.09K ﹤0.01% 1009
2022
Q2
$5K Buy
147
+124
+539% +$5.27K ﹤0.01% 1026
2022
Q1
$2K Sell
23
-11
-32% -$792 ﹤0.01% 1270
2021
Q4
$3K Sell
34
-3
-8% -$359 ﹤0.01% 1137
2021
Q3
$5K Buy
37
+6
+19% +$874 ﹤0.01% 986
2021
Q2
$5K Sell
31
-17
-35% -$2.75K ﹤0.01% 939
2021
Q1
$9K Buy
48
+10
+26% +$2.32K ﹤0.01% 747
2020
Q4
$8K Hold
38
﹤0.01% 777
2020
Q3
$8K Hold
38
﹤0.01% 679
2020
Q2
$7K Buy
38
+33
+660% +$5.78K ﹤0.01% 570
2020
Q1
$1K Buy
5
+1
+25% +$116 ﹤0.01% 990
2019
Q4
$0 Hold
4
﹤0.01% 1476
2019
Q3
$0 Buy
+4
New +$263 ﹤0.01% 1360

Other funds holding TDOC

Glassman Wealth Services's TDOC Position: Q1 2024 in Review

Glassman Wealth Services sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 168 shares — an estimated $3.62K sold.

Glassman Wealth Services first reported a position in TDOC in Q3 2019 and held it in 18 quarters. The position peaked at $10.1K in Q1 2023. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Glassman Wealth Services reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 168 Teladoc Health shares in Q1 2024, an estimated $3.62K.
  • Glassman Wealth Services first reported a position in Teladoc Health in Q3 2019 and held it in 18 quarters.
  • Glassman Wealth Services's Teladoc Health position peaked at $10.1K in Q1 2023.
  • 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.